Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medinotec (MDNC) Research & Development (2022 - 2025)

Medinotec's Research & Development history spans 4 years, with the latest figure at $8326.0 for Q4 2025.

  • For Q4 2025, Research & Development fell 87.98% year-over-year to $8326.0; the TTM value through Nov 2025 reached -$151728.0, down 993.36%, while the annual FY2025 figure was -$91133.0, 307.74% down from the prior year.
  • Research & Development reached $8326.0 in Q4 2025 per MDNC's latest filing, down from $66235.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $69270.0 in Q4 2024 to a low of -$177275.0 in Q1 2025.
  • Average Research & Development over 4 years is -$13789.8, with a median of $2310.0 recorded in 2023.
  • Peak YoY movement for Research & Development: plummeted 562.29% in 2024, then skyrocketed 3400.79% in 2025.
  • A 4-year view of Research & Development shows it stood at $6405.0 in 2022, then plummeted by 57.41% to $2728.0 in 2023, then soared by 2439.22% to $69270.0 in 2024, then plummeted by 87.98% to $8326.0 in 2025.
  • Per Business Quant, the three most recent readings for MDNC's Research & Development are $8326.0 (Q4 2025), $66235.0 (Q3 2025), and -$49014.0 (Q2 2025).